Table 3.
Aetiology, N (%) | 12–14 mm | 15–16 mm | ≥17 mm |
Amyloidosis | 67 (27.9) | 60 (35.7) | 76 (41.5) |
Sarcomeric HCM | 63 (26.2) | 51 (30.4) | 76 (41.5) |
Hypertensive CMP | 71 (29.6) | 40 (23.8) | 17 (9.3) |
Undetermined | 23 (9.6) | 11 (6.5) | 11 (6.0) |
Other | 16 (6.7) | 6 (3.6) | 3 (1.6) |
CMP, cardiomyopathy; HCM, hypertrophic cardiomyopathy.